Global Therapeutic Drug Monitoring Market Projected to Grow at 11.3% CAGR, Reaching $3.72 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Therapeutic Drug Monitoring Industry Market Size Be by 2025?
In the past few years, the market size of therapeutic drug monitoring has witnessed considerable growth. The market, which stood at $2.23 billion in 2024, is projected to reach a value of $2.43 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.9%. The market growth in the historical period can be traced back to several factors including a surge in chronic disease incidents, concerns around drug safety, integration of pharmacogenomics, acceleration in drug development, and a regulatory focus on precision medicine.

What's the Long-Term Growth Forecast for the Therapeutic Drug Monitoring Market Size Through 2029?
In the coming years, a swift expansion is projected for the therapeutic drug monitoring market which is predicted to reach a worth of "$3.72 billion by 2029, escalating at a compound annual growth rate (CAGR) of 11.3%. The predicted growth during the forecast period can be credited to the broadening applications in the field of oncology, the surge in personalized medicine practices, the rising number of elderly people worldwide, the widening scope of point-of-care testing, and the increased spending on pharmaceutical research and development. The forecast period is likely to witness major trends such as personalized medicine, technological progress, enhanced drug development and utilization, point-of-care testing (poct), and the advent of new biomarkers and assay technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

What Are the Key Growth Drivers Fueling the Therapeutic Drug Monitoring Market Expansion?
The advancement in the number of organ transplantation surgeries is predicted to ignite a surge in the therapeutic drug monitoring market. Organ transplantation refers to a surgical procedure which involves the transfer of an organ from one individual, the donor, to another. It has been established that Therapeutic Drug Monitoring (TDM) of immunosuppressive medicines serves as an effective strategy for managing patients who are undergoing solid organ transplantation. The optimization of TDM could prevent either an overdose or underdose that could lead to organ rejection. For instance, an article published by the United Network for Organ Sharing in January 2023, a non-profit US-based organization responsible for overseeing organ transplants, stated that there were a total of 42,887 organ transplants performed in the United States in 2022, marking a 3.7% increase from 2021. Consequently, the escalation in organ transplantation surgeries is fueling the growth of the therapeutic drug monitoring market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

What Are the Key Trends Driving Therapeutic Drug Monitoring Market Growth?
Leading businesses within the therapeutic drug monitoring market are concentrating on the progression of anti-idiotypic antibody technology. This technique improves assay accuracy for precise measurement of biologic drug levels and the evaluation of patient immune responses. Anti-idiotypic antibody technology has positive ramifications for therapeutic drug monitoring as it ensures precise detection and measurement of biologic drug levels, accurate dosing, and tracking patient immune responses. As an example, Bio-Rad Laboratories, an American biotech firm, in June 2024, rolled out new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies for bioanalytical assays. This development advances pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These advanced antibodies increase assay reliability for antibody-drug conjugates (ADCs), a crucial element for the therapeutic drug monitoring market, facilitating precise drug levels and immune response assessments for ideal patient dosage.

How Is the Therapeutic Drug Monitoring Market Segmented?
The therapeutic drug monitoring market covered in this report is segmented -

1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors
2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms
3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs
4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

Subsegments:
1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards
2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment
3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers
4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10069&type=smp

Which Companies Are Leading the Charge in Therapeutic Drug Monitoring Market Innovation?
Major companies operating in the therapeutic drug monitoring market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

Which Regions Are Leading the Global Therapeutic Drug Monitoring Market in Revenue?
North America was the largest region in the therapeutic drug monitoring market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10069

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.